Since CD4+ and CD8+ T cells has been described as a positive prognostic factor in NSCLC [43–45], we performed an analysis of CD4+ and CD8+ T cells in relation to disease survival. The gene discussed is CD4; the disease is non-small cell lung carcinoma.